Nancy T. Chang's Ownership and Derivative Holdings in Immix Biopharma, Inc.

The SEC filing details the ownership and derivative holdings of Dr. Nancy T. Chang in Immix Biopharma, Inc. (IMMX). Dr. Chang, who is a director of the company, directly owns 421,940 shares of common stock. Additionally, she indirectly owns 496,940 shares through Robinhood II, LP, where she serves as the general manager. The filing also reports two derivative holdings: non-transferrable warrants to purchase common stock, each with an exercise price of $2.00 and an expiration date of September 5, 2035. These warrants are exercisable as of September 8, 2025, and cover 316,455 shares of common stock each. The filing emphasizes that Dr. Chang disclaims beneficial ownership of the securities held by Robinhood II, LP, except to the extent of her pecuniary interest.